Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Ozempic: miracle drug or a band-aid for obesity?

Francisco M. Torres, MD
Meds
December 16, 2023
Share
Tweet
Share

An excerpt from Dr. T’s Drop the Fat Diet: 12 Steps to Leaner You Forever.

Semaglutide, a medication often marketed as Ozempic, Wegovy, or Rybelsus, has gained immense popularity in recent years. This is especially true in an age where diabetes and obesity are on the rise. The medication is being seen as a panacea for effortless weight loss. Some doctors and activists have hailed it as a miracle drug that can help shift the conversation around obesity from a judgmental approach to a disease model of metabolic illness.

Obesity, a condition characterized by excessive body fat, is a complex and multifactorial issue that has become a public health concern worldwide. Several factors, including genetics, hormones, stress, and food availability, influence the development of obesity. The interplay between these factors can lead to an imbalance in energy intake and expenditure, resulting in an accumulation of body fat. While genetic and hormonal factors may predispose individuals to obesity, environmental factors such as food availability and stress can exacerbate the condition. Therefore, a comprehensive approach that addresses individual and environmental factors is necessary to prevent and manage obesity.

There is often a tendency to treat obese patients judgmentally. One reason behind this is that obesity is now associated with poverty. People who can only afford processed foods, work too much to cook but do not earn enough to buy expensive pre-made healthy meals, or who have high stress levels due to living in poverty are much more likely to be obese than the wealthy and privileged individuals who we see being celebrated for their fitness and beauty in magazines.

Many celebrity influencers have faced public backlash for promoting their “diet and fitness secrets” while taking all the credit for themselves as experts, even though they are supported by a team of nutritionists, chefs, and personal trainers.

Several healthy meal delivery services claim to be affordable, but in reality, they charge more than $10 per meal per person, which can add up to over $200 per week for one person to eat three meals per day, seven days per week. Similarly, high-end nutritional shakes can cost over $3 per serving, equating to over $100 monthly for one daily nutrition shake.

Preparing meals from scratch may not be feasible for those who work multiple jobs to make ends meet, as they may need more time or resources.

Some have suggested that semaglutide improves this situation and that promoting a “disease model” of obesity can allow overweight people to be treated as patients suffering from illness and not people who make poor life choices.

There is a severe problem at hand – obesity is just one aspect of the nutrition crisis that a growing number of people are facing. Inaccessibility to healthy foods and the abundance of unhealthy foods is not just a matter of gaining weight. It is a matter of shortened life expectancy due to various reasons such as nutrient deficiency, cardiovascular disease, hypertension, and diabetes. These conditions can be caused by unhealthy processed foods, which can be prevented through a healthy diet. Merely reducing caloric intake is not sufficient to prevent any of these conditions. Instead, one needs to increase nutrient density while decreasing the density of unhealthy fats, sugar, and salt.

Is semaglutide merely masking the problem and making it less visually apparent? It is essential to consider whether we can truly solve the issue of obesity by simply prescribing weight loss drugs. Unfortunately, our patients often suffer from nutrient deficiencies due to their inability to afford healthy food, which can ultimately lead to shortened lifespans. This is primarily because they are overworked and underpaid.

The use of drugs for weight management might be a prolonged process, and it is essential for the public to understand that, just like any other ailment, you might have to continue taking it for the remainder of your life.

Our main objective should be to educate readers about the importance of nutrient-dense foods and provide recipes that make these foods more appealing to those who crave unhealthy foods due to stress.

While sharing recipes can make cooking and eating healthy foods more effortless, it is essential to note that it is only helpful if a person can afford the ingredients or has access to cooking facilities.

ADVERTISEMENT

We must come together to address the rising public health concerns. One of the key steps towards this end is to improve the availability of fresh and healthy foods and accessible cooking facilities. While medication can help alleviate specific ailments, it cannot replace the importance of a balanced, nutritious diet. Moreover, providing advice on healthy eating habits will only suffice if people can afford fresh foods. We need to take concrete steps towards making healthy food options more affordable and accessible for everyone and make cooking facilities readily available to ensure that people can prepare nutritious meals at home.

Francisco M. Torres is an interventional physiatrist specializing in diagnosing and treating patients with spine-related pain syndromes. He is certified by the American Board of Physical Medicine and Rehabilitation and the American Board of Pain Medicine and can be reached at Florida Spine Institute and Wellness. 

Prev

Matthew Perry's enduring impact: Advocating for substance use disorder awareness and treatment

December 16, 2023 Kevin 1
…
Next

A test of medical leadership for Penn’s new president

December 16, 2023 Kevin 2
…

Tagged as: Obesity

Post navigation

< Previous Post
Matthew Perry's enduring impact: Advocating for substance use disorder awareness and treatment
Next Post >
A test of medical leadership for Penn’s new president

ADVERTISEMENT

More by Francisco M. Torres, MD

  • Physician work-life balance and family

    Francisco M. Torres, MD
  • A pilgrimage to Italy with prostate cancer

    Francisco M. Torres, MD
  • When life makes you depend on Depends

    Francisco M. Torres, MD

Related Posts

  • Digital advances in the medical aid in dying movement

    Jennifer Lynn
  • Drug ads are a campaign against physician trust

    Judy Salz, MD
  • The complications of drug regulation

    Julie Craig, MD
  • Should drug use be decriminalized?

    Katya Korol and Sarah Fraser, MD
  • The promise of in silico drug development to improve patient outcomes

    Tanja Dowe
  • Drug advertising has helped created victim politics

    Martha Rosenberg

More in Meds

  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
    • The debate on English tests for immigrant nurses

      Lynne Moronski, PhD, MPA, RN | Conditions
    • The FQHC model and medicine’s moral promise

      Sami Sinada, MD | Physician
    • AI companions and loneliness

      Ronke Lawal | Tech
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • Who profits from medical malpractice lawsuits?

      Howard Smith, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
    • The debate on English tests for immigrant nurses

      Lynne Moronski, PhD, MPA, RN | Conditions
    • The FQHC model and medicine’s moral promise

      Sami Sinada, MD | Physician
    • AI companions and loneliness

      Ronke Lawal | Tech
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • Who profits from medical malpractice lawsuits?

      Howard Smith, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...